Parkview Cancer Institute ( Site 0088) is a clinical research site located in Fort Wayne, Indiana, United States 46845.
Crixeo Health Trust Score: 53/100 (POOR). This profile has not yet been claimed by the site owner.
Parkview Cancer Institute ( Site 0088) has participated in 2 clinical trials with 2 currently active.
Therapeutic areas: Carcinoma, Renal Cell.
Sponsors: Merck Sharp & Dohme LLC.
Trust Score: 53/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Parkview Cancer Institute ( Site 0088) has a Crixeo Trust Score of 53/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Parkview Cancer Institute ( Site 0088) has 2 clinical trials on record, with 2 currently active. Their work covers Carcinoma, Renal Cell.
Parkview Cancer Institute ( Site 0088) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.